Terumo Corp.
Company Snapshot
Company Overview
Terumo Corp. is a medical technology company founded in 1921 that manufactures and commercializes medical products and equipment. The company serves various healthcare sectors, including pharmaceuticals, nutritional food supplements, disposable medical devices, cardiovascular systems, blood glucose monitoring systems, and electronic devices.
The company operates its business through its three reportable segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The company offers drug-device combination products through its Cardiac and Vascular Company. The company operates in over 160 countries and has around 30,000 employees globally as of December 31, 2023.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
Company's Business Segments
- Cardiac and Vascular Company : Terumo Cardiovascular Develops, Manufactures Medical Devices that function outside the body in place of the heart and lungs during Cardiac Surgery.
- Medical Care Solutions Company : This segment includes Neurovascular Services, Hospital Care Solutions, Life Care Solutions, Pharmaceutical Solutions.
- Blood and Cell Technologies Company : The Blood and Cell Technologies Company provides solutions to Safely and Effectively process Donated Blood into Blood Products, Collect Blood Components needed for Transfusions, Cell Therapy.
Applications/End User Industries
- Blood Centers
- Bypass Surgery Products
- Medical Institutions
- Regenerative Medicine
- Biotech Companies
- Pharmaceutical
- Cardiac
- Blood Transfusion
- Vascular
- Cell Therapy
- Medical Devices
- Catheters
- Infusion Therapy
- Guidewires
- Parenteral Nutrition
- Research Institutions
- Hospital Care
- Digital Solutions
- Neurovascular
